Health Secretary RFK Jr. Holds Meeting on Advancing Rare Disease Detection, Treatment

Live News Network
1.4K followers
111 Video Views·Dec 16, 2025
Health Secretary Robert F. Kennedy Jr. holds a meeting on advancing rare disease detection and treatment at 11 a.m. ET on Dec 16.
AI Generated·May contain errors
Well, good morning, everyone, and welcome to the Department of Health and Human Services.
I'm Dr. Stephanie Herodopoulos, and I'm Chief of Staff of the Office of the Surgeon General.
And I'm so glad you all could join us today for this amazing announcement on rare diseases.
We are joined by a tremendous group here of people.
We have obviously Secretary Kennedy, our head of HHS, as well as our administrator, Tom Engels, head of HRSA.
We also have Representative Gus Villarroca, Senator Britt, Senator Ron Johnson, and Senator Wicker.
Thank you all for coming and being with us today.
Your presence is strong to the rare disease community and also to all the families.
Thank you for the journey that took you here.
I appreciate how long and how far you came to join us with this announcement, and especially to our panelists.
But every single one that's in the room today, your presence, your invitation was done on purpose because of your advocacy and what you've done in this space.
So even though you might not get a chance to speak at the table, your voices are heard through others, and your presence here is acknowledged by our leadership.
So with that, I'd like to introduce Secretary Robert Kennedy.
Thank you, Stephanie, and welcome to HHS, everybody.
Like Dr. Harkopoulos, I, too, want to thank many individuals for being with us on this historic day,
among them are the patients and families of children who are suffering from general muscular dystrophy and metachromatic leukodystrophy.
I also want to thank the members of Congress who have been instrumental in making this day happen.
Many of them have talked to me directly.
I won't say harangued, but have advocated for this community with great passion and this agency,
and it is their urging that we acted on this so quickly.
Ron Johnson, particularly, I want to thank, who called me in early September and said,
we want to get this done, and I told him that we would do it.
So today is the fulfillment of that promise.
We have Senator Katie Fritt of Alabama, Senator Ron Johnson of Wisconsin,
Senator Roger Wicker of Mississippi, and Congressman Gus Borick of Georgia,
and the HHS Administrator for Health Resources and Services Administration, HRSA, Tom Engels.
I'm proud to announce today that I'm approving the addition of the general muscular dystrophy
and metachromatic leukodystrophy to the recommended uniform screening panel.
Thank you.
And the stakes could not be higher.
Early detection of DMD and MLD allows children to receive FDA-approved therapies at the most effective time,
helping to slow the disease progression and improve their quality of life.
We now have developed cell and gene therapies that can actually cure these diseases,
and if we find and detect children very early on who have suffered from them,
we can save them from a shortened life of misery,
and we can also, we anticipate the private insurance is also going to cover this
because it creates enormous savings for them.
Most children with DMD or MLD are diagnosed at four or five years of age
when significant muscle loss or functional decline have already occurred.
This is too late.
Adding these conditions, the recommended uniform screening panel will encourage newborn screenings
and help clinicians diagnose children earlier than FDA-approved treatments are far more effective.
In April of 2024, the U.S. Food and Drug Administration approved a new gene therapy
which can stop or slow the progression of MLD, but only if administered prior to the onset of symptoms.
Without detection and treatment before symptoms arise, MLD is uniformly fatal.
Several treatments for DMD are approved.
We all know curing this.
New research published in August suggests early identification of DMD in a child improves the outcomes vastly.
That's because clinicians have more time to come up with targeted, personalized treatment plans for DMD.
Without doubt, these early screenings will prevent a severe disability like that in hundreds of children annually.
Early detection will also give families a better chance to avoid long delays,
repeated specialist visits, and financial and emotional strain
that will often define years-long diagnostic search for rare diseases.
These diagnostic odysseys can be emotionally and financially devastating
for families who are in search of answers.
As my uncle, President John F. Kennedy, once said,
although children may be the victims of fate, they will not be the victims of our neglect.
If one in 40,000 newborns are born with MLD and DMD affects one in every 5,000 newborn males,
these so-called rare diseases are not actually that rare.
The Navajo Nation is particularly affected disproportionately.
An incident among Navajos is one in every 2,500.
I have spoken repeatedly to Boone and Egrin, the President of the Navajo Nation, about this,
and he is very excited that we will be able to bring these remedies, these early diagnostics, to his people.
America's children are better, especially because the tools to improve their health outcomes already exist.
Newborn screening isn't just a medical advancement, but a moral imperative.
After we add these conditions to our recommended uniform screening panel, our work is not over.
State adoption of our recommendations comes next.
Tom Engels is going to talk about where we are with the states,
but states will need to add these screenings to their state universal newborn screening program.
At the current level of screening, most MLD and DMD diagnosis are too late.
This is a major reason why approximately 30% of the children with rare diseases do not make it to age 5.
So states should choose to adopt our RUSB recommendations,
and I commend the 14 states that have already introduced legislation mandating alignment with the RUSB.
Their actions will give our youngest citizens the fighting chance that every child deserves.
For reference, the 14 states are Alabama,
and Senator Britt is an attendant and chief of the people who hanged my phone off the hook
to make sure that we could make this available to the people of Alabama, Arizona, California.
Lord, I thank you for your help.
I think Congressman Bill Beck is Iowa, Maryland, Mississippi.
Thank you, Senator.
North Carolina, Ohio, Pennsylvania, Tennessee, Texas, and Virginia.
Timely care is compassionate care, and our children deserve nothing less.
I'm proud of our team here at HHS for helping make this day a reality.
I'm especially thankful to HHS's administrator for the health resource service administration, Tom Engels,
for helping to provide the leadership, technical assistance, and supporting evidence to make today's announcement possible.
Thank you.
And thank all of you.
Thank you.
Thank you so much, Secretary Kennedy.
This is such a momentous day in history that for generations to come,
this day will change the trajectory of lives for children, saving lives.
And I can't think of anything better with a purpose-driven mind than doing what we're doing today.
With that, I'd like to introduce our administrator, Tom Engels of HRSA.
I can't tell you how long and hard, how many hours his staff, his wonderful staff,
and all that might be worked on making this a reality today.
Your staff is truly incredible.
Thank you, Tom Engels, and the floor is yours.
Thank you, Doctor, and I really want to thank Secretary Kennedy.
Once again, he has shown true leadership in helping thousands of families across the state.
Earlier this year, I had a chance to participate in an event with Secretary Kennedy
where we talked about organ transplantation and changes that he was making there.
This is a secretary that knows how to lead.
This is a secretary that takes the bull by the horns
and actually gets the job done when families really need it.
Thank you, Secretary, for your leadership.
The newborn screening panel that we're talking about today, the recommended uniform screening panel,
currently in the United States has existed for about 16 years.
Over 4 million children are born each year, and not all of them have this opportunity to be tested.
Thanks to Secretary Kennedy's leadership,
these two diseases will now be added to that list, but they can be screened.
Not all these children, we can determine simply looking at them to see if they're healthy or not.
Screening has to be done to help these families.
Today, we have about 60 current conditions that are on that list.
We're adding more to this list.
Without newborn screening, families can spend a lot of time wondering what is going on with their children,
how they can help them, and their practitioners could be asking the same questions.
What more do they need to be doing?
Today, we're going to know from the very beginning what might be happening with that child
and give the families hope and opportunities that currently exist, but that they did not know about it soon enough.
As the Secretary mentioned, there are 39 states that HRSA currently funds that helps them with the screening program.
We are going to work with those states to help them.
As the Secretary mentioned, 14 of them are immediately going to be adding to this.
Senator Johnson and I were talking prior to this.
It's great to have a fellow Wisconsinite helping lead the charge.
We are working to make sure that families get this added on.
We want them to work with their state legislatures, and we want them to work with their state Department of Health Services leadership.
I'm a former Deputy Secretary of the Wisconsin Department of Health.
I know the difficult process it takes to add screens to that test, that list.
This is the first step to get that done.
So thank you, Mr. Secretary, for your continued leadership.
I also want to call out one individual from my staff, Laura Kavanaugh,
who is currently the Associate Administrator of the Internal and Child Input Health Program.
She really wanted to get this done, and at the end of this month, she will be retiring,
knowing she got this across the finish line.
So thank you.
Thank you, Mr. Engels.
Okay, now we're going to shift to a few of our policymakers that are here.
We're going to start with Congressman Gus Bilirakis from Florida.
Thank you very much.
I appreciate it very much, Dr. Cardozo.
Thank you for your great work.
Thank you, Senator Kavanaugh.
Thank you, Mr. Secretary, for all your great work.
I'm thinking outside the box.
So very important.
Administrator, we really appreciate it.
This is why we run for office.
Today's announcement represents a monumental era of breakthroughs grounded in human action.
As co-chair of the Congressional Rare Disease Caucus,
I have long worked to ensure that no child suffers due to a lack of diagnosis,
and expanding newborn screening is a critical part of that effort.
Including conditions like MLB and DMV in the newborn screening process is a major step forward.
We couldn't do it without you.
Thank you, everyone.
I can't tell you how much that means to me.
I can't do it without you as well.
By identifying rare diseases early,
we can dramatically improve the child's chances of final treatment,
and in some cases, cure it.
So very exciting.
Supporting the development of treatments alongside these screenings allows us to deliver on the promise of modern science
and give families real hope.
This action also has long-term benefits for our healthcare system.
Early diagnosis helps prevent complications, reduces years of misdiagnosis,
and lowers overall healthcare costs.
It also serves as a powerful catalyst for research, biotechnology innovation,
creations of life-changing therapies for rare or for rare diseases.
Proud to be joined today by the teaching person, wonderful, wonderful teacher,
whose sweet daughter, Maddie, Maddie is here,
has endured significant hardship because of a rare disease.
It was not recognized at first,
even though it could have been identified through a simple blood test.
I look forward to working with Dr. Kennedy, his team,
with Dan Dufour and his team,
and others who have contributed to this effort.
So again, thinking outside the box,
getting rid of the bureaucracy,
and doing the right thing by the American people,
we are the safe line.
So God bless you.
Thank you.
Thank you, Congressman.
Well, going down the line, I'd like to hear from Senator Katie Britt from Alabama.
Thank you so much.
I really appreciate your time today.
What an incredible day.
I want to start with Cecilia Britt.
Thank you so much for sharing your story with me.
When I met you in May, it was the catalyst.
You are what drove me to make sure that we were fighting,
to make sure that we had the proper research for rare disease,
so that every mom and dad out there had the tools they needed to help their little one,
and what helped me fight so hard to make sure that we were here today.
So you are an incredible young woman,
and I am so glad that you are an Alabamian.
I want to thank Secretary Kennedy for your leadership here.
I mean, it's just incredible.
Other secretaries have talked about this.
You are actually putting these things into action.
You are a catalyst for ensuring that families in America,
that parents in America,
actually have the information and the tools that they need to keep their children safe
and give them an opportunity to grow and thrive and live their American dream.
So thank you for not just talking about these things with us,
but putting them into action.
You said timely care is compassionate care, and that's exactly right,
and that's what this does today.
So adding both DMD and LD to the recommended uniform screening journals,
we'll be able to take important steps to make sure that parents at a critical time,
when symptoms aren't necessarily showing up or they're very poor,
are being able to get there quickly and get answers to the problem
to make sure that they can have the proper delivery of the drugs and the treatments that are needed.
So we're so excited about that.
And to Gary and to Casey, thank you for telling this story.
And thank you for elevating your voice.
You are why we're here today.
So you and all of your parents,
and parents across America,
advocating for your children is going to give someone else a chance to have more time.
And so we are all in all of you, and we just want to keep going.
And to all of my colleagues,
Thank you, Senator Brett.
Senator Ranja.
Thank you, Doctor.
Thank you, Administrator.
I particularly want to thank you, Mr. Secretary, for taking all the slings and arrows, all the attacks, hanging in there.
You're doing something very significant.
I just cannot thank you enough.
Continue to thank you.
Like Senator Britt, I want to thank the parents and the patients who have come to Congress,
often when it's not easy, in wheelchairs, talking to the members and making us aware,
educating us of the struggles that you are dealing with.
I championed right to try back in 2018.
I met with the Goldwater Institute.
Two weeks later, I met with a young mom with ALS who has since passed.
She actually passed before we passed right to try.
When I mentioned that I met with the Goldwater Institute about their statewide effort for right to try,
and I was going to advocate for it, tears started streaming down my face.
That was the moment I said, okay, I have a chance.
I met with other ALS patients, Frank Mangione, who has since passed, Matt Galina,
who is still alive today because of an experimental treatment made available through right to try.
Those are the three ALS patients named on right to try.
The fourth patient was Jordan Glynn, not an ALS patient, Gen-Muscular Dysfunction.
At the other end of the spectrum, a child with a rare disease and his mother, Laura, advocating tirelessly.
Again, this is not easy to do, but my message is it makes an impact.
We're here today because of your tireless work.
We passed right to try to give people like Rickett, Matt, Frank, and Jordan hope.
Also, a little bit more freedom to decide for themselves on a drug that hasn't been fully approved,
but they know their condition, they know what the end result is.
Give them the freedom to make that decision rather than a place of fear.
Today's announcement in terms of early screening is going to give families a chance of knowing their child has this condition,
and maybe access treatments may be available through right to try.
Give their loved one, their child, a chance at having a better and fuller life.
Again, this is incredibly important, but it's truthfully made possible because of people like Laura and Jordan,
the other people who made my colleagues aware of these situations.
It would have happened without you, Mr. Secretary, and your people who work with you tirelessly to do what's right.
God bless you.
Thank you.
Keep hanging in there.
Senator Wicker, you are recognized.
Thank you very much.
I want to salute the scientists who've worked for over three decades to get us where we are today.
Back in the early 1990s, Congress and the federal government decided to invest some money in the Human Genome Project,
and we mapped the entire human genome.
In 2001, a number of us learned, and the Congress learned about, the Shen Muscular Dystrophy.
I was visited by the father of a little boy named James, and he had been to Disney World
and didn't want to run around and play like the other children, and they realized something was wrong,
and he was tested, and it was discovered that he had the Shen Muscular Dystrophy.
That led to the introduction on a bipartisan basis of the Shen Muscular Dystrophy Act.
It was co-sponsored by Senator Paul Wellstone, a Democrat from Minnesota.
We felt that we had a Republican co-sponsor in the House.
We had asked for a Democrat, and of course, a year later, he was tragically killed in an airplane crash.
But I want to thank the researchers, and I want to strike a blow for bipartisanship.
We couldn't have gotten this done a quarter century ago if we hadn't had bipartisanship on both sides.
In 2021, the life expectancy of a little boy with the Shen Muscular Dystrophy was 19.
Today, the life expectancy of that same child is in the mid-30s.
Let's say it's 35. That's 16 extra years of life for those patients, and we're only getting better.
We found the dystrophin gene, and our researchers, I cannot tell you how grateful I am for their expertise and the education they've had and for their dedication.
Now, Mr. Secretary and distinguished panelists, because we're going to be able to identify this disease at the time of birth,
there's so much of an extra chance to add not mid-to-late 30s but mid-to-late 40s and on eventually to a cure.
We've done amazing things with a little bit of federal taxpayer money and some expertise from our federal government
and some bipartisan support from both houses of Congress.
This is a red-letter day. It's a monumental achievement.
It'll go down in history, and I'm so honored and grateful to be asked to be a part of it.
Thank you, Senator.
Now I'd like to hear from the folks who have been affected by this.
We have a few panelists here that want to tell their story.
But before I do, I want to make one other point, and this is what's to my attention.
This little girl, Darcy, she got her ANGEL test 30 years ago.
Today, her mother, she fought so hard, Karen, who's the head of the MLB Foundation, to get the diagnostic test.
So it has the sensitivity and specificity test.
So can you imagine 30 years ago today?
She got her ANGEL wings, and here we are in Texas doing that.
Tell me that's not divine.
I'm going to start with First Family with announcing Kendra Riley.
Thank you so much.
Thank you all for being here and for making this possible today.
I cannot tell you how grateful we are.
As you can imagine, it's a very bittersweet day for our family.
I'm here with my husband, Dave, and our daughters, Ava and Kira, behind me.
But at home is our daughter, Libby, who is 7 years old and in hospital.
She couldn't get the same treatment that my daughter, Kira, got.
So we've had to watch her worsen day by day while we're watching Kira thrive.
And she has a bright future ahead, and it's because of these student therapies that exist.
And because of the many of you in this room and many probably not in the room,
we're going to be able to prevent families like ours losing one child in order to save another.
And it just means the world.
Like I said, very bittersweet, but we are very grateful for all of you.
Secretary Kennedy, Dr. Peredopolis, the rest of you, thank you so much.
The entire HHS team, our home state representative, Greg Stanton, and Congressman Schweiker.
There's been so many people along our journey that have helped us get to this point,
and I've had tears pretty much all day.
So thank you so much for making them my tears.
I appreciate it.
Moving on to Alabama, Gary Hamlin.
I just want to thank everybody for having the ability to be here and speak on behalf of my daughter.
She, Grace, in 2021, was the first child in the United States to receive therapy for metachromatic pulmonary disease.
She was the stepping stone for the FDA to get this appraised.
In 2024, the FDA fully appraised it for other kids in the state.
She is a little different from other kids.
She didn't have a sibling that had the disease.
We found it by a bulletin.
In 2020, she had a problem with her gallbladder.
They removed her gallbladder, found a large mass inside her gallbladder.
The pathologist requested further study,
and the pathologist picked up on a neoplasm inside the mass that was associated with metachromatic leukodystrophy.
She requested further study, and come back, found out she had MLD.
No signs, no symptoms of the disease.
September of this year, we went back for her four-year checkup.
Still no signs of the disease.
MRI was negative of the disease.
No faint signs, no nothing of the disease.
We are pleased to have this.
The newborn screening was a must for other kids in the United States.
I want to thank Senator Britt, Senator Coverville, and Representative Robert Aderholt,
which is not far down from where we live at.
Special thanks to Dr. Herodopoulos for all she has done.
Thank you, Secretary Kennedy, for all you have done for this.
This is a life-changing deal for many, many families in the United States.
Thank you, everybody.
I'm Laura McLynn.
I'm the mother to Jordan McLynn, who is right here behind me, who is 16 years old, living with Duchenne.
Secretary Kennedy, in case I forget, I want to start with just a thank you for today.
This is everything to us, our whole community, who has fought so hard for this for so long.
So thank you for making this happen today.
I might be the only one at the table without notes or a phone because I had no idea why I was invited here today.
I kind of had an idea, but I wasn't told.
I was hoping it would have something to do with Duchenne, but I have no notes prepared.
So I'll speak from my heart for just a moment.
I was surprised and happy to see Senator Johnson, who has been a strong advocate for Jordan and Duchenne for many years now.
Since you mentioned Right to Try, I'd like to share a little bit about that part of our journey.
When Jordan was first diagnosed, we were given zero hope.
There were zero FDA-approved therapies.
There were no clinical trials for Jordan.
And when he was five, we started advocating for the Right to Try law because we had hoped it would be a new
and unique pathway whereby he might access a treatment that we heard was in the pipeline.
Well, in the midst of that, Jordan became one of 16 boys in North America to make it into a Phase II clinical trial,
which is what we really wanted.
And now he is almost nine years getting weekly intrusions for an exon skipping therapy that we believe is slowing the progression of his Duchenne.
We're very grateful for that.
That drug was approved through the accelerated approval pathway in the midst of COVID in August of 2020.
Jordan used to travel weekly with me to Chicago for almost four years to get the infusions.
And now other boys living with Duchenne have access to these therapies because of the FDA's accelerated approval process.
So we're very grateful for that.
We now have eight FDA-approved therapies for Duchenne.
My son Jordan is on three of those therapies.
This is the first time I have ever traveled on a plane with Jordan without a wheelchair.
He's been walking.
We can't stop, though.
We have eight FDA-approved therapies.
We have two more who have applications in now with the FDA, Jeremiah Sell and Adaluren.
One of those is not something Jordan can use, but it's something other boys that don't have anything yet for their specific mutation can use.
We have Jeremiah Sell, which has the ability to treat the heart, which, as you know, the heart is a muscle, too,
and ultimately usually the one that fails our boys.
So I wish you could have overheard the breakfast conversation we had with Jordan.
I'm sorry.
We had the most beautiful conversation at breakfast because, as you know, my Jordan is 16,
so newborn screening does not affect Jordan or my family directly.
But we had a suspicion and a hope that today was about newborn screening,
and it meant so much to me to hear my son feel so proud that maybe we were at this point today
and that other boys' future babies born with Duchenne would have opportunities that he did not.
And we even mentioned that this could bring us closer to a cure for Duchenne now that we will know when babies are born.
So thank you to everyone in the room.
I hope I haven't left anyone out.
I'm sure I have.
But, Secretary Kennedy, this means the world to us and our community.
So thank you for being a world changer today.
To all the families today, all your advocates today,
this is the culmination of a difficult year to get diagnostics, therapeutics,
and all of the rest of the process that we've been going through.
So today, we are in the midst of a lost cause.
And there may be things we are able to do.
We are in the midst of a lost cause.
And there may be things we are able to do.
But we are in the midst of a lost cause.
So thank you for all your hard work.
And we are in the midst of a lost cause.
So with that, I'm going to ask Secretary Kennedy, do you have any final remarks before we get to the big drum roll signing?
I was very grateful, again, to all of our elected leaders for listening to the public.
And we had sessions in here yesterday and a couple of months ago on COVID and Lyme disease or invisible diseases.
And they were allowed to remain invisible for so long because this agency was not listening to patients.
And I'm so grateful that we have legislatures now on Capitol Hill, these extraordinary people,
and some of the politicians that we had here, congressional and senatorial representatives we had here yesterday,
who were listening and brought our attention here at HHS to these issues
and allowed us to use the power that we have in this agency to actually do something for these children.
I'm grateful to you.
I'm grateful to the parents.
I know that.
When you have a sick child, it is all-consuming.
And, you know, I have seven children.
And I've often heard the axiom that a parent is only as happy as their least happy children.
And the amount of work that it takes to take care of these children, which you've done so brilliantly,
but in addition to that, you have come to Capitol Hill, brought your children,
endured these hardships to make sure that other children will not suffer as they have.
So I want to thank you on behalf of the country, on behalf of this agency for those efforts.
I really want to thank all of you kids.
I hope I get a chance to meet you after.
Thank you, Secretary Kennedy.
Well, I think it's the big signing of the American Executive Memorandum.
What we're going to do is what I'd like is to have the family members
and the policymakers come behind the Secretary as he's signing.
If any of the children want to come up, up here in the front.
So you are seeing Cutie Patooties.
And then we'll get the family members of people who have been affected by these people behind the Secretary, please.
We're going to have Administrator Tom Angles, once everybody's in place,
and the binders to him so they could sign.
Everyone else, please just maintain your seat.
And we will have some great pictures for you later on,
and you'll get to meet Secretary Kennedy if you're not up here.
Mr. Secretary.
You will now be signing metachromatic.
